Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

5-HT4 agonists developed by Nisshin Flour Milling

June 14, 1996

Carrington Laboratories' Aliminase enters phase III trials

June 14, 1996

Ansan and Boehringer Inglheim enter apafant agreement

June 7, 1996

Single-dose hepatitis A vaccine available

June 7, 1996

Oral toxoid vaccine under development by OraVax

June 7, 1996

Commencement of SYNSORB Cd phase I trial expected

June 7, 1996

Centocor's CenTNF sees positive results

May 31, 1996

Nitto Boseki claims serine protease inhibitors

May 24, 1996

Tobishi CCK-A antagonists for pancreatitis

May 24, 1996

TravelGAM clinical results presented at ASM meeting

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...